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Abstract
Background: Spinal block is a common procedure for lower limbs surgery. Fentanyl, a synthetic opioid and
dexmedetomidine, a selective α2 agonist have been used as adjuvants in spinal anesthesia to prolong
intraoperative and postoperative analgesia. The aim of current study is to compare the efficacy of
dexmedetomidine and fentanyl added to intrathecal bupivacaine in orthopedic procedures in lower limbs.
Methods: In this randomized clinical trial, 90 patients undergoing elective lower limb surgeries were randomly
allocated to three groups. Via intrathecal approach, the patients received 2.5 ml hyperbaric bupivacaine 0.5% plus 5
micrograms dexmedetomidine (BD group), 25 micrograms fentanyl (BF group) or 0.5 ml normal saline (BN group),
respectively. Time to reach the complete motor block, the highest sensory level, regression from block, analgesic
request and duration of the drug effect, hemodynamic changes and side effects were compared between the
groups.
Results: There was no significant difference between the groups regrading time to reach complete motor block,
but time to reach the highest sensory level was shorter in group BD than group BF (6.28 ± 1.75 vs. 7.17 ± 1.45,
p = 0.03). Group BD had significantly lower mean of NRS 6 h after operation (1.90 ± 0.84 vs. 6.16 ± 1.44 vs. 6.30 ± 1.17,
p < 0.001) and longer duration to regress to Bromage 0 (331.60 ± 73.96 vs. 185.56 ± 35.87 vs. 147.03 ± 33.05 min,
p < 0.001), to analgesic request (496.63 ± 70.19 vs. 296.33 ± 44.83 vs. 221.83 ± 22.26 min, p < 0.001), to regress two
sensory levels (149.00 ± 23.17 vs. 88.90 ± 12.85 vs. 69.33 ± 6.67 min, p < 0.001) and to regress to S1 (560.53 ± 81.86 vs.
329.83 ± 44.10 vs. 241.83 ± 22.26 min, p < 0.001). Serial changes in SBP (p = 0.006), DBP (p = 0.03) and HR (p = 0.002) in
group BF were significantly higher than the other two groups. The three groups had comparable side effects.
Conclusions: Using dexmedetomidine as an adjuvant to bupivacaine for spinal anesthesia in lower limb surgeries has
longer duration of sensory and motor block and longer postoperative analgesia.
Trial registration: IRCT registration number: IRCT2017041010599N15, 24 May 2017.
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Background
Lower limb surgeries could be performed under local,
neuroaxial and general anesthesia, but neuroaxial block is
the preferred method. Spinal block has rapid onset, deep
block, lower risk of infection and is cost effective.
However, post-operative pain is an important problem as
the used drugs have limited duration of effect; so the
post-operative analgesic administration is necessary [1, 2].
Administrating the combinations of other classes of
analgesics with local anesthetics has used to increase the
duration and reduce side effects of analgesia [3]. Some
drugs have been used as adjuvants in spinal
anesthesia to prolong intraoperative and postoperative
analgesia [1, 2] including opioids, α2 agonists, neo-
stigmine, vasoconstrictors, etc. Clonidine and dexme-
detomidine are two α2 agonists affecting via pre- and
post-synaptic α2 receptors [4]. Dexmedetomidine has
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been widely used for anesthesia and analgesic pur-
poses. This drug has sedative, anti-anxiety, analgesic,
neuroprotective, and anesthetic-sparing effects [5].
Dexmedetomidine along with other drugs have been
used to increase the duration of analgesia in sub-
arachnoid, epidural and caudal blocks [6, 7].
Fentanyl is a synthetic opioid with central action,
which is used widely for pain control. Intrathecal
fentanyl is usually added to other local anesthetics to
increase anesthesia and analgesia. It has improved spinal
anesthesia and reduced the anesthetic drug related side
effects including pruritus, nausea and vomiting [8].
Dexmedetomidine and fentanyl have been used as
adjuvant to local anesthetics in different surgeries to
provide superior analgesia and to improve the dur-
ation of the block [9–11]. One study on lower limbs
surgery showed a better efficacy with dexmedetomi-
dine [12].
In this study, we aim to compare the efficacy of
dexmedetomidine and fentanyl added to intrathecal
bupivacaine in orthopedic procedures in lower limbs in
terms of block strength and time.
Methods
In this randomized double-blinded clinical trial,
patients between 20 and 65 years old, American Society
of Anesthesiologist (ASA) grade I and II of either
gender undergoing elective lower limb surgeries at
Rasoul-e-Akram Hospital in 2017 were recruited. If
the patients were addict and very obese, had uncon-
trolled hypertension or diabetes mellitus, renal or
hepatic failure, cardiac block or dysrythmia, coagulop-
athies, neurologic disorders, hypersensitivity to any of
the study drugs and known contra indications to
spinal anesthesia, they would be excluded. The study
was reviewed and approved by the Iran University of
Medical Science Ethics Committee and written in-
formed consent was obtained from all subjects before
inclusion in the study.
The study sample size was calculated by n ¼
ðs21þs22Þðz1−α2þz1−βÞ
2
ðx1−x2Þ2
using the results of Yektash et al.(2014)
and through the following formula. Considering α = 0.05,
power of 90% was calculated 29 per each group. Given
Fig. 1 Flowdiagram of study protocol
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that “g” is the number of group, then the total sample size
was 82 by using the following formula: n' = n ∗ √ (g − 1) for
each group as there was possibility that some patients do
not complete the study; 10% drop-out rate, we included
30 patients for each group [13, 14].
Using Block Randomization, according to sample size,
the patients were enrolled into the study (Fig. 1).
The patients were randomly allocated to bupivacaine
(Marcaine spinal 0.5% heavy Astrazeneca, Cenexi, France)
and normal saline (BN), bupivacaine and dexmedetomidine
(Precedex, Hospira co., USA) (BD) and bupivacaine and
fentanyl (Caspian Darou, Rasht, Iran) (BF). The patients re-
ceived 2.5 ml intrathecal hyperbaric bupivacaine with
0.5 ml normal saline (BN) or 5 micrograms dexmedetomi-
dine (BD) or 25 micrograms fentanyl (BF). All medications
were prepared in 3 ml syringes. The patients and physician
evaluating the outcome of the treatments were blinded to
the group allocation.
All the patients were kept for 8 h fasting prior to sur-
gery. Preloading completed with Ringer lactate solution
(5 ml/kg body weight). Standard monitoring including
noninvasive blood pressure (NIBP), ECG, heart rate and
pulse oximetry performed. All patients received supple-
mental oxygen via mask (5 l/min). Under proper
aseptic conditions, spinal anesthesia was given at the
level of L4-L5 interspace in sitting position using a
midline or paramedian approach by a 25G Quincke
spinal needle. The anesthetic medication is injected at
a rate of approximately 2 ml/sec; and then all patients
were made supine.
Blood pressure, heart rate and pulse oximetry were
performed every minute in the first 10 min and then
every five minutes for one hour. We recorded systolic
and diastolic blood pressure and heart rate before re-
gional anesthesia and in the 5, 10, 15, 30, 45 and 60 min
after anesthesia. All data were recorded in a data sheet
specified to each patient.
As we needed anesthetic effects, both sensory and
motor status were assessed prior to the spinal injection,
then every 2 min after injection until reaching the high-
est sensory level and Bromage scale reaching to Bromage
3. After surgery, assessment performed every 10 min
until the time to regression of 2 sensory levels, then
every 20 min until the regression time to the dermatome
S1 and motor scale to Bromage 0.
The motor dermatome level was assessed according to
the Bromage scale:
Bromage 0 (none): Free movement of legs and feet.
Bromage I (Partial): Just able to flex knees with free
movement of feet.
Bromage II (Almost complete): Unable to flex knees,
but with free movement of feet.
Bromage III (Complete): Unable to move legs or feet.
Severity of pain 6 h after surgery was measured by
Numeric Rating Scale (NRS). The patients were asked to
rate their pain from a scale of 0 = no pain to 10 = the worst
possible pain. In case of any side effects it was recorded.
Hypotension was defined as decrease in systolic
blood pressure (SBP) more than 30% of baseline or
SBP < 90 mmHg. If hypotension occurred, 10 mg
Table 1 Baseline findings between groups
BN group
(n = 30)
BF group
(n = 30)
BD group
(n = 30)
P value
Age (years) 39.43 ± 14.82 39.26 ± 15.81 42.20 ± 15.32 0.7
Gender Male 20 (66.7%) 21 (70%) 19 (63.3%) 0.86
Female 10 (33.3%) 9 (30%) 11 (36.7%)
Weight (kg) 69.90 ± 13.45 73.90 ± 11.44 72.40 ± 11.68 0.44
Height (cm) 171.66 ± 7.94 174.06 ± 8.26 171.83 ± 6.21 0.39
Body mass index (kg/m2) 23.65 ± 3.94 24.30 ± 2.79 24.48 ± 3.47 0.62
Table 2 Characteristics of block between three groups
BN group
(n = 30)
BF group
(n = 30)
BD group
(n = 30)
P value
Time from injection to highest sensory level (min) 6.45 ± 1.67 7.17 ± 1.45 6.28 ± 1.75 0.08
Time of two segment regression from the highest sensory level (min) 69.33 ± 6.67 88.90 ± 12.85 149.00 ± 23.17 < 0.001
Time for sensory regression to S1 from highest sensory level (min) 241.83 ± 22.26 329.83 ± 44.10 560.53 ± 81.86 < 0.001
Onset to Bromage 3 (min) 5.55 ± 167 5.05 ± 1.81 4.80 ± 1.74 0.24
Regression to Bromage 0 (min) 147.03 ± 33.05 185.56 ± 35.87 331.60 ± 73.96 < 0.001
Time to rescue analgesia (min) 221.83 ± 22.26 296.33 ± 44.83 496.63 ± 70.19 < 0.001
NRS six hours after surgery 6.30 ± 1.17 6.16 ± 1.44 1.90 ± 0.84 < 0.001
Rahimzadeh et al. BMC Anesthesiology  (2018) 18:62 Page 3 of 7
ephedrine would be administered. Bradycardia was de-
fined as heart rate (HR) below 50 pulses per minute and if
occurred, 0.6 mg atropine would be administered.
Statistical analysis
All data were analyzed using SPSS24 (version 24; SPSS
Inc., Chicago, IL). The results are expressed as Mean ±
standard deviation or percentage. The nominal categor-
ical data between study groups were compared by using
the chi-squared test or Fisher’s exact test as appropriate.
One-way ANOVA and repeated measure of ANOVA
were used to evaluate the changes in the variables during
the study period. p-values of less than 0.05 were consid-
ered statistically significant.
Results
Ninety patients were randomly allocated to three groups
of 30 patients. There was no significant difference be-
tween the groups in baseline findings (Table 1).
Characteristics of block between the three groups
are demonstrated in Table 2. There was significant
differences between BD with BF and BN groups in
regression to Bromage 0 (p < 0.001), two segmental re-
gression (p < 0.001), sensory regression to S1 (p < 0.001),
time to rescue analgesia (p < 0.001) and NRS 6 h after
surgery (p < 0.001) and between BF and BN in regres-
sion to Bromage 0 (p = 0.004), sensory regression to
S1 (p < 0.001), time to rescue analgesia (p < 0.001),
two segmental regression (p < 0.001), and between BD
and BF in the highest sensory level (p = 0.03), but
there was no significantly difference between groups
in onset of Bromage 3 (p > 0.05).
In all three groups, the highest sensory block occurred
in T6 dermatome (Table 3). T5 dermatome was the sec-
ond highest in BD and BF groups, but T7 dermatome
was the second highest block in BN group.
Figures 2 and 3 demonstrate Error bars of systolic and
diastolic blood pressure and heart rate changes between
groups before spinal anesthesia till 60 min after in each
and between groups. Serial changes in SBP, DBP and HR
were significant in each group (p < 0.001); these changes
and reduction in SBP (p = 0.006), DBP (p = 0.03) and HR
(p = 0.002) in BF group were significantly higher than
BD and BN groups.
Nausea, vomiting and chilling were higher in BN
group and hypotension and bradycardia were higher in
BF group, but there were no significant differences be-
tween three groups regarding the treatment side effects
(Table 4).
Table 3 Highest dermatome level of sensory block
BN group
(n = 30)
BF group
(n = 30)
BD group
(n = 30)
T4 0 1 (3.3%) 3 (10%)
T5 3 (10%)1 7 (23.3%) 8 (26.7%)
T6 12 (40%) 16 (53.3%) 12 (40%)
T7 10 (33.3%) 3 (10%) 4 (13.3%)
T8 5 (16.7%) 2 (6.7%) 3 (6.7%)
Fig. 2 Error Bars of Systolic and diastolic blood pressure changes between groups before spinal anesthesia till 60 min after in between groups
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Discussion
In this study, we evaluated the efficacy of three spinal
anesthesia methods, bupivacaine alone or with dexmede-
tomidine or fentanyl in lower limb orthopedic surgeries.
Although there was no significant difference between
groups in time to onset of Bromage 3 and complete
motor block, BD group had lower time to reach the
highest sensory level than BF group, with no difference
with BN group but it was not statistically significant.
(P-value = 0.08).
Similarly, Mahendru et al. [12] found no significant
difference in onset of motor block between dexmedeto-
midine and fentanyl groups. While Yektas [13] and
Ravipati [15] reported faster onset of motor block for
dexmedetomidine compared to fentanyl. Other studies
have also mentioned lower time to reach the highest
sensory level in dexmedetomidine compared to fen-
tanyl [12–19].
The mechanism of how dexmedetomidine prolongs
sensory and motor blockade is not known. Dexmedeto-
midine is a highly-selective α2-adrenergic receptor agon-
ist that causes analgesia by suppression the release of C
fiber transmitters and hyperpolarization of post-synaptic
neurons [13].
In our study, the highest sensory level in BD and BF
group were T6 and T5 while in BN group was T6 and
T7 dermatomes. One study reported the highest sensory
level at T5 dermatome [15] and Mahendru [12] reported
in T6 dermatome. Other study reported the highest
sensory level at T5 dermatome in dexmedetomidine and
T6 in fentanyl group [20].
None of the patients requested analgesic during the
surgery. Bromage 3 occurred in all patients before oper-
ation. Complete regression of motor block (Bromage 0)
was reached in all patients and with the highest duration
in BD group. Moreover, time to regression to S1 sensory
level and regression of two sensory levels in BD group
was significantly longer than the other groups. These pa-
tients also experienced lower pain intensity six hours
after surgery indicative of the highest postoperative anal-
gesia duration in BD group.
Reduced need for analgesics in the post-operation
period, more stable hemodynamics, longer duration of
sensory and motor block for dexmedetomidine have
been reported in previous studies comparing this drug
with other drugs such as clonidine, fentanyl and sufenta-
nil [16, 19, 21–24]. In orthopedic surgeries of lower
Fig. 3 Error Bar of Heart rate changes between groups before spinal anesthesia till 60 min after in between groups
Table 4 Side effects between groups
BN group (n = 30) BF group (n = 30) BD group (n = 30)
Nausea 2 (6.7%) 1 (3.3%) 1 (3.3%)
Vomiting 2 (6.7%) 0 0
Chilling 2 (6.7%) 2 (6.7%) 1 (3.3%)
Pruritus 0 2 (6.7%) 0
Hypotension 0 3 (10%) 1 (3.3%)
Bradycardia 0 3 (10%) 1 (3.3%)
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limb, better results have also been reported for dexme-
detomidine compared to fentanyl [12, 13].
Hemodynamic changes is common in anesthesia medi-
cations. We observed that changes in SBP, DBP and HR
in BF was higher than BD and BN groups, with no
difference between BD and BN patients. The highest
decline occurred 5 min after spinal injection and was
rather stable afterwards. Unlike our findings, other stud-
ies did not report any significant difference between
fentanyl and dexmedetomidine regarding hemodynamic
status [12, 13, 15–18]. Decline in HR and blood pressure
are common effects of opioids. The difference in
hemodynamic findings could be due to the response of
each individual to the drug, demographic profile, volume
of IT injectate and volume of diluent used.
Side effects may occur by using any anesthesia medica-
tions. The best medication is the one with the highest
efficacy and lowest side effects. We observed no signifi-
cant difference in the rate of hypotension, bradycardia,
nausea and vomiting and chilling between groups. Previ-
ous studies have reported different rate of side effects.
Similar to our findings, Ravipati [15] observed pruritus
only in fentanyl group while nausea and vomiting was
more common in dexmedetomidine, with no significant
difference between groups. There is also only one study
reporting increase in hemodynamic side effects, brady-
cardia and hypotension, in dexmedetomidine [24].
Another important side effect of anesthesia medica-
tions is respiratory system suppression. However, we
observed no respiratory suppression. First, fentanyl com-
pared to other opioids is less likely to cause respiratory
suppression. Second, this complication is not common
in dexmedetomidine.
In order to reach better efficacy, we can increase the
dose of the used dexmedetomidine. Gupta [19] reported
that increasing the dose of dexmedetomidine from
2.5 μg to 10 μg would show better and longer sensory
and motor block, with longer duration of anesthesia and
comparable hemodynamic and side effects profile.
Conclusion
In conclusion, using dexmedetomidine as an adjuvant to
bupivacaine for intrathecal analgesia in lower limb sur-
geries has longer duration of sensory and motor block,
longer postoperative analgesia with low side effects. All
three treatments had lower side effects with no differ-
ence between groups.
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